Journal of Applied Physiology Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 102: 1520-1527, 2007. First published December 28, 2006; doi:10.1152/japplphysiol.00881.2006
8750-7587/07 $8.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
102/4/1520    most recent
00881.2006v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chow, S.-E.
Right arrow Articles by Chen, J.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chow, S.-E.
Right arrow Articles by Chen, J.-K.

Resveratrol attenuates oxLDL-stimulated NADPH oxidase activity and protects endothelial cells from oxidative functional damages

Shu-Er Chow,1 Ya-Ching Hshu,2 Jong-Shyan Wang,3 and Jan-Kan Chen2

1Center for General Studies; 2Department of Physiology, College of Medicine; and 3Graduate Institute of Rehabilitation Science, Chang Gung University, Taoyuan, Taiwan

Submitted 9 August 2006 ; accepted in final form 18 December 2006

trans-Resveratrol (RSV) has been shown to have cardioprotective effect during ischemia-reperfusion through reactive oxygen species (ROS)-scavenging activity. Elevated ROS has been implicated in the initiation and progression of atherosclerosis. The nicotinamide adenine dinucleotide phosphate oxidase (NOX) is a major source of vascular ROS formation. In the present study, we show that exposure of vascular endothelial cells (EC) to oxidized low-density lipoproteins (oxLDL) results in elevations of NOX activity and cellular ROS levels. The oxLDL effects are effectively suppressed by RSV or astringinin (AST), either before or after oxLDL exposure. In this study, we show that RSV or AST treatment appears to suppress NOX activity by reducing the membrane association of gp91phox and Rac1, two protein species required for the assembly of active NOX complex. Exposure to RSV or AST protects EC from oxidative functional damages, including antiplatelet activity and mononucleocyte adhesion. In addition, ANG II-induced NOX activation is also attenuated. These results suggest that RSV or AST protects EC from oxLDL-induced oxidative stress by both direct ROS scavenging and inhibition of NOX activity.

oxidized low-density lipoprotein; nicotinamide adenine dinucleotide phosphate oxidase; reactive oxygen species



Address for reprint requests and other correspondence: J.-K. Chen, Dept. of Physiology, College of Medicine, Chang Gung Univ., 259 Wen-Hwa 1st Rd., Kwei-Shan, Taoyuan 333, Taiwan (e-mail: jkc508{at}mail.cgu.edu.tw)




This article has been cited by other articles:


Home page
VASC ENDOVASCULAR SURGHome page
K. G. Maier
Nicotinamide Adenine Dinucleotide Phosphate Oxidase and Diabetes: Vascular Implications
Vascular and Endovascular Surgery, August 1, 2008; 42(4): 305 - 313.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.